Literature DB >> 20606644

Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells.

Daniel Skuk1, Martin Paradis, Marlyne Goulet, Pierre Chapdelaine, David M Rothstein, Jacques P Tremblay.   

Abstract

Myogenic cell transplantation is an experimental approach for the treatment of myopathies. In this approach, transplanted cells need to fuse with pre-existing myofibers, form new myofibers, and generate new muscle precursor cells (MPCs). The last property was fully reported following myoblast transplantation in mice but remains poorly studied with human myoblasts. In this study, we provide evidence that the intramuscular transplantation of postnatal human myoblasts in immunodeficient mice generates donor-derived MPCs and specifically donor-derived satellite cells. In a first experiment, cells isolated from mouse muscles 1 month after the transplantation of human myoblasts proliferated in vitro as human myoblasts. These cells were retransplanted in mice and formed myofibers expressing human dystrophin. In a second experiment, we observed that inducing muscle regeneration 2 months following transplantation of human myoblasts led to myofiber regeneration by human-derived MPCs. In a third experiment, we detected by immunohistochemistry abundant human-derived satellite cells in mouse muscles 1 month after transplantation of postnatal human myoblasts. These human-derived satellite cells may correspond totally or partially to the human-derived MPCs evidenced in the first two experiments. Finally, we present evidence that donor-derived satellite cells may be produced in patients that received myoblast transplantation.

Entities:  

Mesh:

Year:  2010        PMID: 20606644      PMCID: PMC2956934          DOI: 10.1038/mt.2010.128

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  41 in total

1.  Pax7 and myogenic progression in skeletal muscle satellite cells.

Authors:  Peter S Zammit; Frederic Relaix; Yosuke Nagata; Ana Pérez Ruiz; Charlotte A Collins; Terence A Partridge; Jonathan R Beauchamp
Journal:  J Cell Sci       Date:  2006-04-11       Impact factor: 5.285

Review 2.  Defining the transcriptional signature of skeletal muscle stem cells.

Authors:  Z Yablonka-Reuveni; K Day; A Vine; G Shefer
Journal:  J Anim Sci       Date:  2007-09-18       Impact factor: 3.159

Review 3.  Skeletal muscle stem cells.

Authors:  Margaret Buckingham; Didier Montarras
Journal:  Curr Opin Genet Dev       Date:  2008-07-30       Impact factor: 5.578

4.  Molecular markers for myoblast transplantation in GRMD.

Authors:  R J Bartlett; N J Sharp; W Y Hung; J N Kornegay; A D Roses
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

5.  First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up.

Authors:  Daniel Skuk; Marlyne Goulet; Brigitte Roy; Vincent Piette; Claude H Côté; Pierre Chapdelaine; Jean-Yves Hogrel; Martin Paradis; Jean-Pierre Bouchard; Michel Sylvain; Jean-Guy Lachance; Jacques P Tremblay
Journal:  Neuromuscul Disord       Date:  2006-12-04       Impact factor: 4.296

6.  Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells.

Authors:  Daniel Skuk; Marlyne Goulet; Brigitte Roy; Pierre Chapdelaine; Jean-Pierre Bouchard; Raynald Roy; Francine J Dugré; Michel Sylvain; Jean-Guy Lachance; Louise Deschênes; Hélène Senay; Jacques P Tremblay
Journal:  J Neuropathol Exp Neurol       Date:  2006-04       Impact factor: 3.685

7.  In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study.

Authors:  Elisa Negroni; Ingo Riederer; Soraya Chaouch; Marzia Belicchi; Paola Razini; James Di Santo; Yvan Torrente; Gillian S Butler-Browne; Vincent Mouly
Journal:  Mol Ther       Date:  2009-07-21       Impact factor: 11.454

8.  Human muscle precursor cells give rise to functional satellite cells in vivo.

Authors:  Janine Ehrhardt; Karima Brimah; Carl Adkin; Terence Partridge; Jennifer Morgan
Journal:  Neuromuscul Disord       Date:  2007-06-27       Impact factor: 4.296

9.  High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.

Authors:  J Huard; S Verreault; R Roy; M Tremblay; J P Tremblay
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Implanted myoblasts not only fuse with myofibers but also survive as muscle precursor cells.

Authors:  S N Yao; K Kurachi
Journal:  J Cell Sci       Date:  1993-08       Impact factor: 5.285

View more
  26 in total

1.  Gene transfer using HACs: a key step closer to ex vivo gene therapy using autologous gene-corrected cells to treat muscular dystrophy.

Authors:  Jacques P Tremblay; Robert M Frederickson
Journal:  Mol Ther       Date:  2011-12       Impact factor: 11.454

2.  Not an inside job: how can transplantation of relatively few exogenous satellite cells do what thousands of endogenous cells cannot?

Authors:  Jacques P Tremblay; Daniel Skuk; Robert Frederickson
Journal:  Mol Ther       Date:  2011-01       Impact factor: 11.454

3.  Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy.

Authors:  Sébastien Goudenege; Yann Lamarre; Nicolas Dumont; Joël Rousseau; Jérôme Frenette; Daniel Skuk; Jacques P Tremblay
Journal:  Mol Ther       Date:  2010-08-03       Impact factor: 11.454

Review 4.  Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks.

Authors:  Fabrizio Rinaldi; Rita C R Perlingeiro
Journal:  Transl Res       Date:  2013-11-14       Impact factor: 7.012

5.  Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.

Authors:  Tomoya Fukawa; Benjamin Chua Yan-Jiang; Jason Chua Min-Wen; Elwin Tan Jun-Hao; Dan Huang; Chao-Nan Qian; Pauline Ong; Zhimei Li; Shuwen Chen; Shi Ya Mak; Wan Jun Lim; Hiro-Omi Kanayama; Rosmin Elsa Mohan; Ruiqi Rachel Wang; Jiunn Herng Lai; Clarinda Chua; Hock Soo Ong; Ker-Kan Tan; Ying Swan Ho; Iain Beehuat Tan; Bin Tean Teh; Ng Shyh-Chang
Journal:  Nat Med       Date:  2016-05-02       Impact factor: 53.440

Review 6.  Gene and cell-mediated therapies for muscular dystrophy.

Authors:  Patryk Konieczny; Kristy Swiderski; Jeffrey S Chamberlain
Journal:  Muscle Nerve       Date:  2013-03-29       Impact factor: 3.217

7.  Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice.

Authors:  Radbod Darabi; Robert W Arpke; Stefan Irion; John T Dimos; Marica Grskovic; Michael Kyba; Rita C R Perlingeiro
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

Review 8.  Hydrogel biomaterials and their therapeutic potential for muscle injuries and muscular dystrophies.

Authors:  Rachel Lev; Dror Seliktar
Journal:  J R Soc Interface       Date:  2018-01       Impact factor: 4.118

9.  Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice.

Authors:  Jinhong Meng; Soyon Chun; Rowan Asfahani; Hanns Lochmüller; Francesco Muntoni; Jennifer Morgan
Journal:  Mol Ther       Date:  2014-02-26       Impact factor: 11.454

Review 10.  The emerging biology of muscle stem cells: implications for cell-based therapies.

Authors:  C Florian Bentzinger; Yu Xin Wang; Julia von Maltzahn; Michael A Rudnicki
Journal:  Bioessays       Date:  2012-08-06       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.